SK bioscience shares extend gains on expectations for Bill Gates meeting

[Source: SK bioscience]

SK bioscience shares extended gains Friday on reports that Bill & Melinda Gates Foundation co-chair Bill Gates was to meet the management of the Korean vaccine maker, timed with the domestic shipment of Korea’s first Covid-19 vaccine.

SK bioscience shares were 2.4 percent higher at 129.500 won ($100) after going as high as 133,000 won following the rise of 4.6 percent on the previous session.

A local media reported Bill Gates will have a meeting with the South Korean vaccine manufacturer to discuss Covid-19 vaccine production and distribution.

SK bioscience developed SKYCovione, the country’s first homegrown Covid-19 vaccine, which was approved by local health authorities in June. The company received 4.4 billion won funding from Bill & Melinda Gates Foundation for vaccine development.

The meeting has raised expectations for a push for global marketing of the Korean vaccine.

[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]